Sayaka Ikeda
YOU?
Author Swipe
View article: Impact of Enterococcus faecium 129 BIO 3B-R on Helicobacter pylori eradication therapy side effects in adult patients: a randomized, double-blind, placebo-controlled study
Impact of Enterococcus faecium 129 BIO 3B-R on Helicobacter pylori eradication therapy side effects in adult patients: a randomized, double-blind, placebo-controlled study Open
Managing the side effects of diarrhea, which is associated with intestinal microbial dysbiosis, is a crucial challenge in Helicobacter pylori eradication therapy. The aim of this study is to explore whether administration of a probiotic st…
View article: P-167 comparison of laboratory and clinical outcomes for piezo-ICSI and conventional-ICSI over 1,000 cycles in an RCT
P-167 comparison of laboratory and clinical outcomes for piezo-ICSI and conventional-ICSI over 1,000 cycles in an RCT Open
Study question In this study, we compared the laboratory and clinical outcomes of piezo-intracytoplasmic sperm injection (p-ICSI) with conventional-ICSI (c-ICSI) using a prospective randomisation method. Summary answer Results from 1,000 c…
View article: Human papillomavirus vaccine to prevent <scp>CIN3</scp> or worse (<scp>CIN3</scp>+): A nationwide case–control study in Japan
Human papillomavirus vaccine to prevent <span>CIN3</span> or worse (<span>CIN3</span>+): A nationwide case–control study in Japan Open
An increase in cervical cancer incidence has been reported in Japan. The Ministry of Health, Labor, and Welfare of Japan has resumed the active recommendation of regular HPV vaccines in 2022. In Japan, the preventive effect of CIN3+ in the…
View article: Impaired Consciousness Due to Hyperammonemia During S-1 Administration for Unresectable Pancreatic Cancer
Impaired Consciousness Due to Hyperammonemia During S-1 Administration for Unresectable Pancreatic Cancer Open
A 71-year-old woman diagnosed with unresectable locally advanced pancreatic cancer was initially treated with gemcitabine and nab-paclitaxel as first-line therapy. The tumor exhibited no significant progression; however, after 12 cycles, t…
View article: Effectiveness of catch‐up and routine program of the 9‐valent vaccine on cervical cancer risk reduction in Japan
Effectiveness of catch‐up and routine program of the 9‐valent vaccine on cervical cancer risk reduction in Japan Open
In 2013, the national human papillomavirus (HPV) immunization program began. However, in June 2013, Japan's Ministry of Health, Labor and Welfare (MHLW) announced a “temporary” suspension of its recommendation for the human papillomavirus …
View article: Disseminated Mycobacterium avium Complex Infection in a Patient Treated With Immunosuppressants
Disseminated Mycobacterium avium Complex Infection in a Patient Treated With Immunosuppressants Open
Mycobacterium avium complex (MAC) is an important cause of opportunistic infections in immunosuppressed hosts, such as patients with HIV infection and solid organ transplant recipients. MAC disease usually presents in 4 distinct clinical c…
View article: Figure S2 from Epidemiologic and Clinical Analysis of Cervical Cancer Using Data from the Population-Based Osaka Cancer Registry
Figure S2 from Epidemiologic and Clinical Analysis of Cervical Cancer Using Data from the Population-Based Osaka Cancer Registry Open
5-years relative survival rate, by stage and age group (1976-2010, SCC and adenocarcinoma of the cervix)
View article: Table S2 from Epidemiologic and Clinical Analysis of Cervical Cancer Using Data from the Population-Based Osaka Cancer Registry
Table S2 from Epidemiologic and Clinical Analysis of Cervical Cancer Using Data from the Population-Based Osaka Cancer Registry Open
Difference of tumor stage of cervical cancer, by age group (1976-2012)
View article: Data from Epidemiologic and Clinical Analysis of Cervical Cancer Using Data from the Population-Based Osaka Cancer Registry
Data from Epidemiologic and Clinical Analysis of Cervical Cancer Using Data from the Population-Based Osaka Cancer Registry Open
Cervical cancer screening rate is extremely low and the governmental recommendation of HPV vaccine has been suspended for 5 years in Japan. Here, we utilized data from the Osaka Cancer Registry, collected between 1976 and 2012, to evaluate…
View article: Table S1 from Epidemiologic and Clinical Analysis of Cervical Cancer Using Data from the Population-Based Osaka Cancer Registry
Table S1 from Epidemiologic and Clinical Analysis of Cervical Cancer Using Data from the Population-Based Osaka Cancer Registry Open
Changes in number of cervical cancer cases, by treatment procedure
View article: Table S2 from Epidemiologic and Clinical Analysis of Cervical Cancer Using Data from the Population-Based Osaka Cancer Registry
Table S2 from Epidemiologic and Clinical Analysis of Cervical Cancer Using Data from the Population-Based Osaka Cancer Registry Open
Difference of tumor stage of cervical cancer, by age group (1976-2012)
View article: The COVID-19 Pandemic in Japan: Its impact on a Newborn’s Childcare Environment and on the Mother’s Sense of Loneliness
The COVID-19 Pandemic in Japan: Its impact on a Newborn’s Childcare Environment and on the Mother’s Sense of Loneliness Open
The COVID-imposed social isolation of Japanese mothers has significantly increased their already existing sense of loneliness.We report here on the changes that have occurred in the environment of home childcare and in the mother's feeling…
View article: Table S3 from Epidemiologic and Clinical Analysis of Cervical Cancer Using Data from the Population-Based Osaka Cancer Registry
Table S3 from Epidemiologic and Clinical Analysis of Cervical Cancer Using Data from the Population-Based Osaka Cancer Registry Open
Difference of treatment procedures for localized of cervical cancer, by age group (1976-2012)
View article: Figure S2 from Epidemiologic and Clinical Analysis of Cervical Cancer Using Data from the Population-Based Osaka Cancer Registry
Figure S2 from Epidemiologic and Clinical Analysis of Cervical Cancer Using Data from the Population-Based Osaka Cancer Registry Open
5-years relative survival rate, by stage and age group (1976-2010, SCC and adenocarcinoma of the cervix)
View article: Figure S1 from Epidemiologic and Clinical Analysis of Cervical Cancer Using Data from the Population-Based Osaka Cancer Registry
Figure S1 from Epidemiologic and Clinical Analysis of Cervical Cancer Using Data from the Population-Based Osaka Cancer Registry Open
10-years relative survival rate, by period and by stage (1976-2010, invasive cervical cancer)
View article: Data from Epidemiologic and Clinical Analysis of Cervical Cancer Using Data from the Population-Based Osaka Cancer Registry
Data from Epidemiologic and Clinical Analysis of Cervical Cancer Using Data from the Population-Based Osaka Cancer Registry Open
Cervical cancer screening rate is extremely low and the governmental recommendation of HPV vaccine has been suspended for 5 years in Japan. Here, we utilized data from the Osaka Cancer Registry, collected between 1976 and 2012, to evaluate…
View article: Table S3 from Epidemiologic and Clinical Analysis of Cervical Cancer Using Data from the Population-Based Osaka Cancer Registry
Table S3 from Epidemiologic and Clinical Analysis of Cervical Cancer Using Data from the Population-Based Osaka Cancer Registry Open
Difference of treatment procedures for localized of cervical cancer, by age group (1976-2012)
View article: Figure S1 from Epidemiologic and Clinical Analysis of Cervical Cancer Using Data from the Population-Based Osaka Cancer Registry
Figure S1 from Epidemiologic and Clinical Analysis of Cervical Cancer Using Data from the Population-Based Osaka Cancer Registry Open
10-years relative survival rate, by period and by stage (1976-2010, invasive cervical cancer)
View article: Table S1 from Epidemiologic and Clinical Analysis of Cervical Cancer Using Data from the Population-Based Osaka Cancer Registry
Table S1 from Epidemiologic and Clinical Analysis of Cervical Cancer Using Data from the Population-Based Osaka Cancer Registry Open
Changes in number of cervical cancer cases, by treatment procedure
View article: Disparities among Japanese municipalities in recommendations for routine and catch‐up HPV vaccinations
Disparities among Japanese municipalities in recommendations for routine and catch‐up HPV vaccinations Open
In November 2021, the government of Japan announced a reversal of its decision in 2013 to suspend the previous proactive recommendation for HPV vaccination. However, the program for young girls to receive routine and catch‐up vaccinations …
View article: EP068/#585 Long-term effect of HPV vaccination against HPV infection in Japanese young women
EP068/#585 Long-term effect of HPV vaccination against HPV infection in Japanese young women Open
Objectives In Japan, public funding for HPV vaccine began in 2010 for girls aged 13–16 (birth years 1994–1997), and women born in 1994 turned 25 in 2019. We aimed to verify long-term effect of bivalent HPV vaccine in women aged 25. Methods…
View article: Can Catch-Up Vaccinations Fill the Void Left by Suspension of the Governmental Recommendation of HPV Vaccine in Japan?
Can Catch-Up Vaccinations Fill the Void Left by Suspension of the Governmental Recommendation of HPV Vaccine in Japan? Open
In 2013, the Ministry of Health, Labor, and Welfare (MHLW) in Japan announced a suspension of the governmental recommendation for routine HPV vaccinations. In 2020, MHLW started individual notifications of HPV vaccine to the targeted girls…
View article: Genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: A systematic review and meta-analysis
Genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: A systematic review and meta-analysis Open
HPV prevalence is high among Japanese women. The nonavalent vaccine is likely to have the greatest impact on reducing cervical cancer incidence and mortality in Japan.
View article: Effectiveness of human papillomavirus vaccine against cervical precancer in Japan: Multivariate analyses adjusted for sexual activity
Effectiveness of human papillomavirus vaccine against cervical precancer in Japan: Multivariate analyses adjusted for sexual activity Open
Japanese girls aged 12–16 years are offered free human papillomavirus (HPV) vaccination and cervical cancer screening is conducted with cytology and not HPV testing from the age of 20 years. So far, no study has analyzed the effect of HPV …
View article: Development of information dissemination methods that contribute to improving maternal and child healthcare using social networking sites: a community-based cross-sectional study in Japan
Development of information dissemination methods that contribute to improving maternal and child healthcare using social networking sites: a community-based cross-sectional study in Japan Open
Background In recent years, feelings of isolation among mothers caring for small children has become a significant social issue in Japan. The purpose of this study is to develop a message to alleviate their loneliness, to evaluate the impa…